Core Insights - CareTrust REIT experienced a transformational year in 2025, achieving record investment activity and expanding its team significantly, which supports its growth strategy in the UK and seniors housing sectors [5][7]. Investment Activity - CareTrust reported total investments of $1.8 billion in 2025, surpassing its previous record set in 2024, which contributed to a 17.3% year-over-year growth in normalized FFO per share [2][7]. - The fourth quarter alone saw approximately $562 million in investments, including CareTrust's first SHOP deal involving three Texas communities with 270 units [7][8]. - The company's investment pipeline is approximately $500 million, with a focus on UK care homes and U.S. skilled nursing facilities [12]. Financial Performance - In the fourth quarter, normalized FFO increased by 42.7% quarter-over-quarter to $104.1 million, with a normalized FFO per share increase of 17.5% to $0.47 [14]. - For the full year, normalized FFO per share rose by 17.3% to $1.76, while normalized FAD per share increased by 14.3% to $1.76 [14]. Guidance and Future Outlook - CareTrust provided guidance for 2026, projecting normalized FFO per share between $1.90 and $1.95, indicating a midpoint growth of approximately 9.4% year-over-year [6][19]. - The company is entering 2026 with strong liquidity, including around $100 million in cash and a $1.2 billion revolving credit facility, alongside low leverage metrics [17]. Strategic Initiatives - The company doubled its professional team in 2025 and executed strategic initiatives, including the acquisition of Care REIT to enter the UK care home market [3][5]. - Management emphasized ongoing diversification across geography, asset types, and operator relationships, which is expected to enhance growth opportunities [2][4]. Market Position and Competition - CareTrust is experiencing competitive conditions in the SHOP sector, with cap rates compressing as investors seek exposure to improving operating trends [13]. - The company maintains a focus on achieving unlevered IRR in the low double digits for its SHOP investments, while also exploring opportunities in the UK market [21][23].

Investor Presentation and Supplemental Information Fourth Quarter 2025 Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other federal securities laws. These forward-looking statements can be identified by the use of words such as "expect," "plan," "will," "estimate," "project," "intend," "believe," "guidance," and other similar expressions that do not relate to historical matters. These forward-looking statements ...

Core Insights - Apollo Commercial Real Estate Finance (ARI) is actively managing its real estate owned (REO) portfolio to enhance cash flow and maximize exit value while focusing on four retained assets [2][6][19] Group 1: Property Overview - The Brook is a newly built Class A multifamily tower with 591 residential units and approximately 20,000 square feet of retail space, currently 56% leased with strong leasing momentum of 20-40 units per month [1] - The retail component at The Brook is 88% leased to Din Tai Fung, with expected occupancy next year [1] Group 2: Financial Performance - For Q4 2025, ARI reported distributable earnings of $37 million, or $0.26 per diluted share, and full-year distributable earnings of $139 million, or $0.98 per diluted share [5][10] - The company ended 2025 with a total loan portfolio of approximately $8.8 billion, achieving a weighted average unlevered yield of 7.3% [16] Group 3: Liquidity and Financing - ARI concluded 2025 with $151 million in liquidity and over $430 million in unencumbered assets, alongside $1.8 billion in added financing capacity [4][17] - The company is contemplating a Q1 dividend near $0.25 per share, pending board approval [4][20] Group 4: Strategic Initiatives - Management is implementing cost-saving initiatives at The Mayflower hotel, expecting a notable increase in net cash flow once completed [7] - The Courtland Grand is undergoing value-add upgrades to enhance group business, with management evaluating restoration options following a fire incident [7] Group 5: Portfolio Management - ARI is managing four retained properties, including The Brook and The Mayflower, to stabilize operations and optimize monetization timing [6][19] - The Massachusetts pre-development portfolio involves zoning changes aimed at increasing site value [8]

Dividend Announcement - Orchid Island Capital, Inc. declared a monthly cash dividend of $0.12 per share for February 2026, payable on March 30, 2026, to shareholders of record as of February 27, 2026, with an ex-dividend date of February 27, 2026 [1][7] Company Overview - Orchid Island Capital, Inc. is a specialty finance company that invests in Agency RMBS (Residential Mortgage-Backed Securities) on a leveraged basis, focusing on traditional pass-through Agency RMBS and structured Agency RMBS [4] Shareholder Distribution Requirements - To qualify as a real estate investment trust (REIT), the company must distribute at least 90% of its REIT taxable income annually to stockholders, excluding net capital gains [2] Share Count - As of February 11, 2026, the company had 190,281,372 shares of common stock outstanding, an increase from 183,345,932 shares as of January 31, 2026 [3] RMBS Portfolio Characteristics - The RMBS portfolio as of January 31, 2026, includes various categories of Agency RMBS, with a total fair value of $10,492,794, where Fannie Mae assets account for 53.3% and Freddie Mac assets account for 46.7% [11][12] Borrowings and Counterparty Exposure - The company has total borrowings of $9,993,257, with various counterparties, and the average borrowing rate is 3.86% [13]

Core Viewpoint - AGNC (NASDAQ: AGNC) offers a high forward yield of 12.8%, but its earnings are declining, raising concerns about the sustainability of its dividend [1][2] Group 1: AGNC Overview - AGNC is a mortgage real estate investment trust (mREIT) that generates income by buying mortgages and mortgage-backed securities (MBS) [2] - The projected EPS for AGNC is $1.51, which covers its forward dividend rate of $1.44, indicating a potential for dividend sustainability [1] - AGNC's current trading discount is attributed to declining earnings, which may lead to challenges in maintaining its dividend if the payout ratio exceeds 100% [2][3] Group 2: Interest Rate Impact - AGNC's profitability relies on the Fed's short-term rates being lower than long-term rates; however, recent interest rate cuts have not effectively reduced MBS yields and borrowing costs [2] - The company has been forced to take out loans at higher rates to purchase lower-yielding MBS, creating an ongoing imbalance if the real estate market remains weak [2] Group 3: Comparison with Vici Properties - Vici Properties (NYSE: VICI) is presented as a more stable investment option compared to AGNC, as it operates as an equity REIT that owns physical properties and has a consistent occupancy rate [3][4] - Vici has maintained a 100% occupancy rate since its IPO in 2018 by locking tenants into long-term leases, which are indexed to the Consumer Price Index (CPI) [5] - Vici's business model allows it to raise rents in line with inflation, and it has successfully increased its dividend every year since its IPO, currently offering a forward yield of 6% [6]

Core Insights - Innovative Industrial Properties (IIPR) is set to announce its Q4 2025 results on February 18, 2026, with expected earnings of $1.81 per share [2] - The company has a market capitalization of $1.35 billion and a P/E ratio of 11.38, indicating its valuation relative to earnings [3] Financial Performance - IIPR's stock opened at $48.01, with a 52-week low of $44.58 and a high of $75.71 [3] - The company has a quick ratio and current ratio of 2.75, and a debt-to-equity ratio of 0.19, suggesting strong liquidity and low leverage [3] Dividend Information - IIPR announced a quarterly dividend of $1.90, representing an annualized dividend of $7.60 and a yield of 15.8% [4] - The dividend payout ratio is currently at 180.09%, indicating a high proportion of earnings being distributed as dividends [4] Analyst Ratings - Weiss Ratings downgraded IIPR from "hold (c-)" to "sell (d+)" [6] - Piper Sandler raised the target price from $43.00 to $44.00 while maintaining an "underweight" rating [6] - The consensus rating for IIPR is "Reduce" with a price target of $68.20 [6] Insider Transactions - CFO David Jon Smith purchased 600 shares at an average price of $45.90, totaling $27,540 [7] - Chairman Alan D. Gold bought 2,600 shares at an average price of $49.09, amounting to $127,634 [7] - Insiders have acquired a total of 4,200 shares worth $201,434 in the last ninety days, with insiders owning 2.00% of the stock [7] Institutional Ownership - Institutional investors own 70.58% of IIPR's stock, with notable increases in stakes from several hedge funds [8][9] - Headlands Technologies LLC increased its stake by 109.4%, now holding 758 shares valued at $42,000 [8] - Northwestern Mutual Wealth Management Co. boosted its stake by 1,304.0%, owning 2,106 shares valued at $113,000 [9] Company Overview - Innovative Industrial Properties is a REIT focused on acquiring and managing specialized industrial properties leased to state-licensed operators in the U.S. cannabis industry [10] - The company was founded in 2016 and is headquartered in San Diego, California, being the first publicly traded REIT in the medical-cannabis sector [11]

Core Viewpoint - Ventas, Inc. is a leading real estate investment trust (REIT) focusing on senior housing and healthcare properties, with a diverse portfolio that includes senior housing communities, medical office buildings, and hospitals [1] Group 1: Financial Performance - Ventas reported an "outstanding year" in 2025, driven by its senior housing segment, with a 9% increase in normalized funds from operations (FFO) per share and a 15% growth in same-store SHOP cash net operating income (NOI) [3] - The company's enterprise value exceeded $50 billion, with fourth-quarter annualized NOI and SHOP NOI reaching $2.5 billion and $1.3 billion, respectively [4] Group 2: Market Position and Strategy - Ventas competes with other REITs like Welltower and Healthpeak Properties in the healthcare real estate sector [1] - The company employs a "1, 2, 3 strategy" focusing on senior housing growth, value-creating investments, and portfolio cash flow, which has contributed to its financial success [3] Group 3: Stock Performance and Analyst Insights - On February 10, 2026, RBC Capital set a new price target of $91 for VTR, suggesting a potential increase of about 9.92% from its trading price of $82.79 at that time [2] - The stock's current price is $82.87, showing a slight increase of 0.15% from the previous day, with fluctuations between $82.67 and $83.14 during the trading day [2] Group 4: Future Outlook - Ventas has increased its quarterly dividend and expects continued growth in 2026, led by its Senior Housing Operating Portfolio (SHOP) [4]

Core Viewpoint - SL Green Realty Corp. will participate in a roundtable discussion at Citi's 31st Annual Global Property CEO Conference on March 2, 2026, featuring key executives including the Chairman and CEO, Chief Investment Officer, and Chief Financial Officer [1]. Company Overview - SL Green Realty Corp. is Manhattan's largest office landlord and operates as a fully integrated real estate investment trust (REIT) focused on acquiring, managing, and maximizing the value of Manhattan commercial properties [3]. - As of December 31, 2025, SL Green held interests in 56 buildings totaling 31.4 million square feet, which includes ownership interests in 28.0 million square feet of Manhattan buildings and 2.7 million square feet related to debt and preferred equity investments [3].

Core Insights - The cannabis industry is evolving with expanding legalization and improving regulations, making cannabis REITs attractive for lower-risk exposure compared to traditional cannabis stocks [1][2] - Cannabis REITs provide predictable cash flow and higher dividend yields, which can stabilize portfolios during market volatility [2] - Heading into Q1 2026, several cannabis REITs are highlighted for their resilience and disciplined capital deployment strategies [3] Industry Overview - Cannabis REITs generate revenue by owning or financing real estate associated with licensed cannabis operators, avoiding direct involvement in cannabis production or sales [1] - The focus on long-term leases and structured financing agreements allows these REITs to benefit from stable income streams [1][2] Key Companies to Watch - **Innovative Industrial Properties, Inc. (IIPR)**: A pioneer in the cannabis REIT space, focusing on specialized properties for cultivation and processing, with a national footprint across 19 states [6][7] - **NewLake Capital Partners, Inc. (NLCP)**: Engages in sale-leaseback transactions and build-to-suit projects, owning both dispensary and production properties, emphasizing disciplined underwriting [11][12] - **Chicago Atlantic Real Estate Finance, Inc. (REFI)**: Focuses on senior secured lending to licensed cannabis operators, generating income through interest rather than rent [14][15] Financial Performance - IIPR has a strong balance sheet with resilient revenue, supporting reliable dividend payments despite sector volatility [10][11] - NewLake has demonstrated steady revenue growth and consistent profitability, appealing to income investors [13][14] - REFI is known for its high dividend yield and robust cash flow, maintaining reasonable leverage and sufficient liquidity for ongoing lending [18][19] Market Positioning - Cannabis REITs are positioned to benefit from potential federal reforms that could improve tenant profitability and credit quality, indirectly enhancing their performance [4] - The focus on established operators with operational history helps reduce tenant default risk across these REITs [9][12]

Core Insights - Omega Healthcare Investors reported strong fourth-quarter results with adjusted funds from operations (AFFO) of $0.80 per share and funds available for distribution (FAD) of $0.76 per share, reflecting growth driven by new investments and reduced interest expenses [1][3][6] - The company achieved a revenue increase to $319 million in the fourth quarter, up from $279 million year-over-year, with net income rising to $172 million compared to $116 million in the prior-year quarter [2][4] Financial Performance - Fourth-quarter FAD increased by one cent from the previous quarter, supported by $485 million in new investments and approximately $1 million in lower net interest expenses [1] - Full-year AFFO and FAD growth exceeded 8% year-over-year, aided by $1.1 billion in capital deployment [3][6] - The dividend payout ratio decreased to 84% of AFFO and 88% of FAD [3][6] Portfolio and Investment Activity - Omega now owns or partners in 1,111 facilities and completed over $1.1 billion in transactions during 2025, including expansions and new stakes in various facilities [5][12] - The company is monitoring the Genesis Chapter 11 bankruptcy, with expectations for resolution in Q3 or Q4 of 2026 [5][9][10] - Recent investments include a $93 million purchase of 9.9% of Saber's operating company equity and a $109 million acquisition of skilled nursing facilities in Georgia [13][14] Balance Sheet and Leverage - Omega significantly strengthened its balance sheet by reducing funded debt by over $700 million, including a $600 million note payoff, resulting in a leverage ratio of 3.51x [6][7] - The company ended 2025 with $27 million in cash and over $1.7 billion in revolver capacity, alongside a new $2 billion at-the-market program [7][8] Guidance and Future Outlook - Full-year 2026 adjusted FFO guidance is set between $3.15 and $3.25 per share, factoring in completed investments and scheduled loan repayments [16] - Management indicated a conservative approach to RIDEA underwriting and is considering increasing the dividend, contingent on board decisions [18] Regulatory Environment - Recent legislative changes addressed a 4% Medicare cut, and minimum staffing standards were repealed, which Omega welcomed [17] - The company anticipates minimal impact from CMS's proposal for flat rates in 2027 due to low Medicare Advantage exposure [17]